Your browser doesn't support javascript.
loading
Cutaneous side effects of inhibitors of the RAS/RAF/MEK/ERK signalling pathway and their management.
Manousaridis, I; Mavridou, S; Goerdt, S; Leverkus, M; Utikal, J.
Affiliation
  • Manousaridis I; Department of Dermatology, Venereology and Allergology, University Medical Centre Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
J Eur Acad Dermatol Venereol ; 27(1): 11-8, 2013 Jan.
Article in En | MEDLINE | ID: mdl-22540151
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Eruptions / MAP Kinase Signaling System / Extracellular Signal-Regulated MAP Kinases / Protein Kinase Inhibitors / Neoplasms / Antineoplastic Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Female / Humans / Male Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2013 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Eruptions / MAP Kinase Signaling System / Extracellular Signal-Regulated MAP Kinases / Protein Kinase Inhibitors / Neoplasms / Antineoplastic Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Female / Humans / Male Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2013 Document type: Article Affiliation country: Alemania Country of publication: Reino Unido